Lantern Pharma LTRN
NASDAQ LTRN
$0.64 -0.03 (-4.05%)
At close: Oct 19, 2026 · 4:00 PM EDT

Lantern Pharma (LTRN) Other Non Operating Income (2021 - 2026)

Updated

Lantern Pharma's Other Non Operating Income was $2.13 million in Q2 2026, up 932.0% from $206,140 a year earlier.

Analysis

Lantern Pharma (LTRN) Other Non Operating Income (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Lantern Pharma's Other Non Operating Income was $2.29 million through Jun 30, 2026, up 259.9% year-over-year; for FY2025, it came in at $421,125, down 39.2% from FY2024.

  • Other Non Operating Income shows a four-year compound annual growth rate of 27.3% (FY2021 to FY2025).
  • In earlier years, Other Non Operating Income was $692,869 in FY2024 (-39.8%), $1.15 million in FY2023, -$31,548 in FY2022 and $160,550 in FY2021.
  • The Q2 2026 figure marks the highest quarterly Other Non Operating Income in data going back to Q2 2021.
  • Compared with a year earlier, Other Non Operating Income was higher in two of the last six quarters, with growth averaging 179.7%.
  • The best year-over-year quarter for Other Non Operating Income over five years was Q2 2026 (growth of 932.0%); the worst was Q3 2025 (a decline of 85.2%).
  • Per Business Quant data, LTRN's Other Non Operating Income in the three quarters before Q2 2026 was $33,916 (Q1 2026), $56,070 (Q4 2025) and $71,456 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn
10 Lantern Pharma 7.95 Mn -28.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.14 Mn
Mar 31, 2026 33,916.00
Dec 31, 2025 56,070.00
Sep 30, 2025 71,456.00
Jun 30, 2025 206,140.00
Mar 31, 2025 87,459.00
Dec 31, 2024 -140,194.00
Sep 30, 2024 482,527.00
Jun 30, 2024 260,295.00
Mar 31, 2024 90,241.00
Dec 31, 2023 424,074.00
Sep 30, 2023 115,777.00
Jun 30, 2023 326,076.00
Mar 31, 2023 284,721.00
Dec 31, 2022 370,489.00
Sep 30, 2022 -171,648.00
Jun 30, 2022 -152,591.00
Mar 31, 2022 -77,798.00
Dec 31, 2021 28,148.00
Sep 30, 2021 17,679.00
API Access

Lantern Pharma Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=LTRN&period=max&api_key=YOUR_API_KEY